|
PKI's Revenue Growth by Quarter and Year
Perkinelmer Inc's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
PKI Revenue (in millions $) |
FY 2021 |
FY 2020 |
FY 2019 |
FY 2018 |
IV Quarter |
January |
-
|
3,738.36
|
531.90
|
572.92
|
III Quarter |
October |
-
|
608.39
|
524.28
|
509.60
|
II Quarter |
July |
-
|
542.05
|
543.30
|
521.79
|
I Quarter |
April |
1,259.44
|
556.17
|
505.38
|
510.89
|
FY |
|
1,259.44
|
5,444.97
|
2,104.86
|
2,115.20
|
PKI Revenue first quarter 2021 Y/Y Growth Comment |
Perkinelmer Inc achieved in the first quarter 2021, above Company average Revenue surge of 126.45% year on year, to $ 1,259.44 millions.
Among companies who have reported first quarter 2021 results in the Laboratory Analytical Instruments industry only one Company has achieved higher year on year Revenue results in the first quarter 2021. While Perkinelmer Inc' s Revenue doubling of 126.45% ranks overall at the positon no. 305 in the first quarter 2021.
|
PKI Revenue ( Y/Y Growth %) |
2021
|
2020 |
2019 |
2018 |
IV Quarter |
January |
- |
602.83 % |
-7.16 % |
6.06 % |
III Quarter |
October |
- |
16.04 % |
2.88 % |
12.31 % |
II Quarter |
July |
- |
-0.23 % |
4.12 % |
8.82 % |
I Quarter |
April |
126.45 % |
10.05 % |
-1.08 % |
14.07 % |
FY |
|
- |
158.69 % |
-0.49 % |
10.09 % |
PKI Revenue (Quarter on Quarter Growth %) |
2021
|
2020 |
2019 |
2018 |
IV Quarter |
January |
- |
514.47 % |
1.45 % |
12.43 % |
III Quarter |
October |
- |
12.24 % |
-3.5 % |
-2.34 % |
II Quarter |
July |
- |
-2.54 % |
7.5 % |
2.13 % |
I Quarter |
April |
-66.31 % |
4.56 % |
-11.79 % |
-5.42 % |
FY (Year on Year) |
|
- |
158.69 % |
-0.49 % |
10.09 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
17.32 % |
1.8 % |
-6.7 % |
(Apr 04 2021) |
|
(Jan 01 2017) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
17.32 % |
1.8 % |
-6.7 % |
(Apr 04 2021) |
|
(Jan 01 2017) |
|
Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021 |
Perkinelmer Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
40.52 % |
0.76 % |
-100 % |
(Jan 03 2021) |
|
|
PKI's I. Quarter Q/Q Revenue Comment |
In the I. Quarter 2021 Perkinelmer Inc disclosed fall in Revenue from the fourth quarter by -66.31% to $ 1,259.44 millions, from $ 3,738.36 millions released in the previous quarter.
Although periodic circumstance normally fuel I. Quarter 2021 results, this simply was not enough to recover PKI's achievement, Elisa Dubois, market advisor situated in Brussel pointed out and continued that average sequential Revenue growth is at 0.76% for Perkinelmer Inc.
Within Laboratory Analytical Instruments industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Perkinelmer Inc's Revenue growth quarter on quarter, overall rank is 2101. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
40.52 % |
0.76 % |
-100 % |
(Jan 03 2021) |
|
|
PKI's I. Quarter Q/Q Revenue Comment |
In the I. Quarter 2021 Perkinelmer Inc reported fall in Revenue from the previous quarter by -66.31% to $ 1,259.44 millions, from $ 3,738.36 millions released in the previous quarter.
Although seasonal influence usually fuel I. Quarter 2021 results, this simply has not been sufficient to recover Perkinelmer Inc's outcome, Elisa Dubois, market advisor situated in Brussel said.
Within Laboratory Analytical Instruments industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Perkinelmer Inc's Revenue growth quarter on quarter, overall rank is 2101. |
|
Perkinelmer Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Apr 03 2022) |
12 Months Ending (Jan 02 2022) |
12 Months Ending (Sep. 30, 2015) |
12 Months Ending IV. Quarter |
12 Months Ending IV. Quarter |
Cumulative Revenue 12 Months Ending |
$ 2,966.05 |
$ 0.00 |
$ 2,262.63 |
$ 2,238.51 |
$ 2,238.51 |
Y / Y Revenue Growth (TTM) |
40.91 % |
- |
1.76 % |
4.32 % |
4.32 % |
Year on Year Revenue Growth Overall
Ranking |
# 288 |
# 419 |
# 831 |
# 956 |
# 1332 |
Seqeuential Revenue Change (TTM) |
32.5 % |
- |
0.95 % |
3.9 % |
3.9 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 941 |
# 441 |
# 572 |
# 638 |
# 1211 |
Cumulative Revenue growth
Comment |
Perkinelmer Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 40.91% year on year, to $ 2,966 millions if the fiscal year would have ended in Apr 03 2022. Perkinelmer Inc's trailing twelve months Revenue growth was higher than company's average 5.57% and higher than % growth in Jan 02 2022. But from the previous reporting period increase was less at 32.5 % from $2238.51 millions recorded in twelve months ending a quarter before. Yet this was validation of positive momentum, as the usual sequential growth is at 1.93%. The momentum was even higher sequentially showed at 32.5 % increase from $2238.51 millions in the period from Jan 02 2022 to IV. Quarter.
Within the Healthcare sector 31 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 288, from total ranking in previous quarter at 419. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
17.32 % |
1.93 % |
-6.7 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
53.71 % |
5.57 % |
-11.31 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 4 |
Sector |
# 84 |
S&P 500 |
# 941 |
|
Cumulative Revenue growth
Comment |
Perkinelmer Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 40.91% year on year, to $ 2,966 millions if the fiscal year would have ended in Apr 03 2022. Perkinelmer Inc's trailing twelve months Revenue growth was higher than company's average 5.57% and higher than % growth in Jan 02 2022. But from the previous reporting period rise was less at 32.5 % from $2238.51 millions achieved in twelve months ending a quarter before. Still it was validation of positive momentum, as the average Q/Q TTM growth stands at 1.93%. The progress was much stronger from the previous reporting period clinched at 32.5 % increase from $2238.51 millions in the period from Jan 02 2022 to IV. Quarter.
Within the Healthcare sector 31 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 288, from total ranking in previous quarter at 419. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
17.32 % |
1.93 % |
-6.7 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
53.71 % |
5.57 % |
-11.31 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 4 |
Sector |
# 84 |
S&P 500 |
# 941 |
Companies with similar Revenue fall for the quarter ending Apr 03 2022 within Healthcare Sector | Y/Y Change % | Revenue for the quarter ending Apr 03 2022 | Pfizer Inc | 75.98% | $ 75.977 millions |
|